Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
A novel therapy from Bluebird Bio Inc and Celgene Corp for patients nearing death from an aggressive form of blood cancer appears to get more effective over time, wiping out signs of disease in more than half of those treated in a small trial.
A single infusion of the...